Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Monitoring of Neuroplastic Effects in Stroke Rehabilitation: Long-term Recovery Prognosis and Therapy Optimization Via Biomarkers

NCT07919301 is registered in ClinicalTrials.gov with Kutahya Health Sciences University as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07919301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Monitoring of Neuroplastic Effects in Stroke Rehabilitation: Long-term Recovery Prognosis and Therapy Optimization Via Biomarkers
Lead sponsor
Kutahya Health Sciences University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
February 1, 2028
Enrollment
72 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, upper extremity paresis

Arms

As registered; 3 arms.

  • Conventional Rehabilitation Active comparatorConventional rehabilitation program, Home exercise program

    Conventional rehabilitation, 45 minutes per session, 5 days per week for 4 weeks (20 sessions): neurodevelopmental approaches, functional upper-limb exercises, task-oriented training, and stretching and strengthening exercises. From week 4 to week 12: standardized home exercise program. Intervention: Conventional rehabilitation program; Home exercise program

  • Low-Dose VR: Conventional Rehabilitation + VR 2 Days/Week ExperimentalConventional rehabilitation program, Home exercise program, Neuroforma virtual reality training

    Conventional rehabilitation as in the control arm plus Neuroforma virtual reality training, 30 minutes per session, 2 days per week for 4 weeks (8 sessions). From week 4 to week 12: the same standardized home exercise program. Intervention: Neuroforma virtual reality training; Conventional rehabilitation program; Home exercise program

  • High-Dose VR: Conventional Rehabilitation + VR 5 Days/Week ExperimentalConventional rehabilitation program, Home exercise program, Neuroforma virtual reality training

    Conventional rehabilitation as in the control arm plus Neuroforma virtual reality training, 30 minutes per session, 5 days per week for 4 weeks (20 sessions). From week 4 to week 12: the same standardized home exercise program. Intervention: Neuroforma virtual reality training; Conventional rehabilitation program; Home exercise program

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Change in Fugl-Meyer Assessment for Upper Extremity (FMA-UE) Motor Score From Baseline to Week 12 Baseline and week 12 (8 weeks after the end of the 4-week intervention)

    Upper-limb motor impairment measured with the motor domain of the FMA-UE (33 items scored 0 to 2; total 0 to 66, higher scores indicate better motor function), administered by an assessor blinded to group allocation. Change = week-12 score minus baseline score.

Lead sponsor's other trials

Kutahya Health Sciences University, most recent start first.

Similar trials

Same condition (Paresis) and phase, most recent start first.